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Many of the major advances in our understanding of how functional brain imaging signals
relate to neuronal activity over the previous two decades have arisen from physiological
research studies involving experimental animal models. This approach has been successful
partly because it provides opportunities to measure both the hemodynamic changes that
underpin many human functional brain imaging techniques and the neuronal activity about
which we wish to make inferences. Although research into the coupling of neuronal
and hemodynamic responses using animal models has provided a general validation of
the correspondence of neuroimaging signals to specific types of neuronal activity, it
is also highlighting the key complexities and uncertainties in estimating neural signals
from hemodynamic markers. This review will detail how research in animal models
is contributing to our rapidly evolving understanding of what human neuroimaging
techniques tell us about neuronal activity. It will highlight emerging issues in the
interpretation of neuroimaging data that arise from in vivo research studies, for example
spatial and temporal constraints to neuroimaging signal interpretation, or the effects of
disease and modulatory neurotransmitters upon neurovascular coupling. We will also
give critical consideration to the limitations and possible complexities of translating data
acquired in the typical animals models used in this area to the arena of human fMRI.
These include the commonplace use of anesthesia in animal research studies and the fact
that many neuropsychological questions that are being actively explored in humans have
limited homologs within current animal models for neuroimaging research. Finally we will
highlighting approaches, both in experimental animals models (e.g. imaging in conscious,
behaving animals) and human studies (e.g. combined fMRI-EEG), that mitigate against
these challenges.
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INTRODUCTION
“One of the difficulties in understanding the brain is that it is like
nothing so much as a lump of porridge.”
Richard L. Gregory (Gregory, 1997)
Human functional brain imaging techniques now play a promi-
nent role in much neuroscience and psychological research.
Unlike many other organs in the body, assigning function or
aspects of functions, in space or time to particular components
of the brain based on even a very detailed analysis of its struc-
ture alone is extremely difficult. Although we have learned much
from neuropsychological research in human subjects or experi-
mental animal research studies, there can be little doubt that the
possibilities for understanding afforded by any technique that can
provide a spatiotemporal readout of changes in brain function are
immense. It is thus perhaps unsurprising that the rate of publica-
tion of scientific papers incorporating functional neuroimaging
now exceeds 10 per day (Kim and Ogawa, 2012). Beyond aca-
demic communities, these tools and the images they produce have
also captured public interest and provided renewed opportunities
for neuroscientists to engage with publics on both scientific mat-
ters and upon issues at the science-society interface (Racine et al.,
2005).
For more than 20 years, the non-invasive neuroimaging tech-
nique of functional magnetic resonance imaging (fMRI) based
on blood oxygen level dependent (BOLD) signal changes has
been used to estimate neural signals in the human brain (Ogawa
et al., 1990). Prior to this, positron emission tomography (PET)
firmly established the possibilities for human neuroimaging
based on surrogate hemodynamic markers. Since the human
application of these hemodynamic based neuroimaging tech-
niques, substantial effort has been directed toward improving our
understanding of functional brain imaging signals, the hemo-
dynamic changes that give rise to them, and the relationship
of these changes to underlying neuronal activity (Figure 1).
Although it is widely appreciated amongst scientific communities
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FIGURE 1 | Schematic illustration of the neurophysiological processes
underpinning hemodynamic neuroimaging signals. The boxed
processes linked by thick gray arrows around the outside represent
components of interest to those focussing on “parametric neurovascular
coupling,” whereas the more detailed processes illustrated in the center
represent important concepts in for investigation of “physiological
neurovascular coupling.” The relationships between the illustrated
biophysical or physiological components, as well as the baseline conditions
upon which changes are superimposed, may be mediated by the factors
illustrated in Figure 6.
that the relationships between activity within heterogeneous
neuronal populations and neuroimaging signals are complex,
rather indirect, and incompletely understood, many research
papers continue to report neuroimaging signals as “measures of
neuronal activity,” which they are not. In addition, it has been
shown that the presence of brain “activation” images in scientific
papers results in higher ratings of scientific quality even where
the images provide no additional information to the reader
(Mccabe and Castel, 2008). It is thus increasingly important
that we both build our understanding of precisely what func-
tional neuroimaging signals do tell us about brain activity, and
ensure that improved frameworks for the interpretation of brain
imaging data are effectively communicated. In this review, we
will use the terms neuroimaging or functional brain imaging to
refer to hemodynamic imaging techniques as applied to human
subjects, rather than the broader definition which includes
electroencephalography (EEG) or magnetoencephalography
(MEG).
Neuroimaging signals arise because of a coupling between
changes in neural activity, metabolism, and hemodynamics
(blood flow, oxygenation, and volume) in the brain, termed
neurovascular coupling (Figure 1; Villringer, 1997; Logothetis
and Wandell, 2004; Logothetis, 2008). Studies of neurovascular
and neurometabolic coupling have therefore been central to
the progress that has been made so far in investigating what
neuroimaging signals tell us about neuronal activity. Important
insights have arisen from research using animal models, in our
laboratory and elsewhere, in which detailed measurements of
functional brain imaging signals and/or the hemodynamic and
neuronal events underpinning them can be made (Mathiesen
et al., 2000; Norup Nielsen and Lauritzen, 2001; Smith et al.,
2002; Devor et al., 2003, 2005; Martindale et al., 2003; Jones
et al., 2004; Sheth et al., 2004; Berwick et al., 2005, 2008;
Hewson-Stoate et al., 2005; Martin et al., 2006a,b, 2012; Hillman
et al., 2007; Franceschini et al., 2008; Boorman et al., 2010;
Kim et al., 2010). It is possible, in animal models, to explore in
detail the changes that occur in each component of the complex
system linking neuronal activity to neuroimaging signal changes,
as illustrated in Figure 1. Thus, a number of landmark papers
(e.g. Logothetis et al., 2001) have now established the general
validity of fMRI signal changes as indicators of altered neuronal
activity: there is overwhelming empirical evidence that increases
in BOLD fMRI signals in healthy cortical structures reflect
increased neuronal activity in those structures. However, the
boundaries of this broad statement and limits to its generaliz-
ability are becoming increasingly important as neuroimaging
is applied to study the whole brain in both health and disease
contexts.
The focus of this paper will therefore be upon the excep-
tions, complexities and remaining uncertainties around neu-
roimaging signal interpretation, as revealed predominantly by
in vivo experimental animal research into neuroimaging sig-
nals and neurovascular coupling. We shall begin by outlining
the main approaches to investigating neuroimaging signals and
neurovascular coupling in experimental animal models, includ-
ing a brief overview of the major techniques. We shall then
review some of the key research questions that these approaches
allow us to address along with some of the main insights
provided thus far. We shall review recent research highlight-
ing areas where the relationships between neuronal activity
and hemodynamic changes are more complex and discuss the
implications of this for neural signal estimation in human neu-
roimaging. Finally we will turn attention to the experimental
animal models themselves, their limitations, as well as new pos-
sibilities to investigate neurovascular coupling directly in human
subjects.
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INVESTIGATING NEUROIMAGING SIGNALS USING
EXPERIMENTAL ANIMAL MODELS
Research using experimental animal models to investigate neu-
roimaging signals and their relationship to neuronal activity
has approached the issue from two converging perspectives.
On the one hand there has been an emphasis on determin-
ing the parametric relationships between neuronal activity and
neuroimaging signals, including characterization of the mathe-
matical relationships between signals, estimation of the hemody-
namic impulse response function (HIRF, see Figure 2 and section
Characterization of hemodynamic impulse response functions),
and the development of comprehensive biophysical models of
neurovascular coupling. We shall refer to this approach as being
concerned with “parametric neurovascular coupling,” emphasiz-
ing the concurrent measurement of signals in different com-
ponents of the neurovascular-neuroimaging system, illustrated
schematically in Figure 1 (outer processes). On the other hand,
attempts have been made to determine the physiological mecha-
nisms of neurovascular coupling, with a focus on the key chemical
mediators and modulators, and the relative involvement of differ-
ent cell types including astrocytes, neurons, pericytes, endothelial
cells, and vascular smooth muscle cells. We shall refer to this
approach as being concerned with “physiological neurovascu-
lar coupling,” emphasizing the biochemical and physiological
mechanisms that mediate the relationships between the neu-
ronal, metabolic, and hemodynamic components, illustrated in
FIGURE 2 | Illustration of the hemodynamic impulse response function
(HIRF, dashed gray line), which typically comprises two gamma
functions (red and blue lines), together approximating the
hemodynamic responses present in often noisy acquired
neuroimaging data (solid gray line). The various parameters required to
specify the HIRF are illustrated. Variations in these parameters that are not
accounted for can lead to inaccurate detection of “activity” in neuroimaging
studies. Some of the factors that might alter these parameters are
illustrated in Figure 6.
Figure 1 (inner detail). The former approach is more directly
relevant to the development of strategies to analyze neuroimag-
ing data and our ability to make general judgments regarding
the effects of experimental manipulations on the magnitude of
underlying neuronal signals, whereas the latter is critical if we are
to improve our detailed understanding of the neurophysiological
events that these signals represent. Convergence of both perspec-
tives is important for progressing our ability to estimate neural
signals from functional brain imaging data acquired in an increas-
ingly broad range of scenarios. With this distinction in mind, we
shall now briefly walk through the principle methodologies being
applied in this field and outline how they contribute to either
approach. A summary of the main techniques used to improve
understanding of neuroimaging signals in experimental animal
models is provided in Table 1 and for a fuller review the reader is
directed to recent publications by Devor et al. (2012, 2014) and
Zhao et al. (2014c).
fMRI FOR INTERROGATING NEUROIMAGING SIGNALS
To some extent it is “by definition” that investigations of neu-
rovascular coupling usually require measurement of both the
neural and vascular components of the overall system. In para-
metric neurovascular coupling research this is predominantly the
case and so experimental designs in which multiple data acquisi-
tion methods can be combined have become the workhorse of
this field. Because of the high degree of inter-trial (and inter-
subject) variability inherent in hemodynamic measurements in
particular, concurrent acquisition of neuronal and hemodynamic
data provides significant statistical and data modeling advan-
tages (in addition to reducing animal numbers). Combining
neuroimaging techniques that are used in humans (such as fMRI)
with electrophysiological techniques to measure neuronal signals
would appear the most parsimonious approach to elucidating
neuroimaging-neural signal relationships. These data provide
direct insight into the quantitative relationships between neu-
roimaging and neural signals. Furthermore, small-animal fMRI
systems, though a combination of reduced bore size (and accord-
ingly other hardware including gradient coils), smaller radiofre-
quency coils and increased field strength are routinely able to
resolve voxels approximately an order of magnitude smaller than
obtainable in human fMRI. High field strength fMRI in animal
models has enabled researchers to study the fine detail of hemo-
dynamic responses, with sub-second temporal precision and
in-plane voxel sizes of <100μm (see section Heterogeneous dis-
tribution of fMRI signals sources revealed by high field strength
fMRI). However, combining this approach with direct measures
of neuronal activity is problematic for a number of reasons.
Firstly, electrodes to record neuronal activity will introduce arti-
facts into the imaging data. These can be minimized by care-
ful electrode design, choice of materials, and image acquisition
parameters, but it is very difficult to completely avoid distortion
of imaging data at precisely the point where it is of most interest
(where the electrode is positioned). Secondly, fMRI in particu-
lar makes use of large, rapidly changing electromagnetic fields
as part of the data acquisition process which can severely distort
the electrophysiological measurement of neural signals. Whilst an
increasing number of laboratories have been able to find ways
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Table 1 | Overview of principle methods used to investigate neuroimaging signals and neurovascular coupling.
Technique Data streams Main advantages Relative disadvantages Usable in
humans?
High field fMRI BOLD, CBV, CBF Cross-species technique, whole
brain imaging
High cost, difficult to combine with
other techniques, limited spatial and
temporal resolution
Yes
Near infrared
spectroscopy
Oxy-, deoxy, and total
hemoglobin
High temporal resolution, low cost
human neuroimaging
Poor spatial resolution, limited depth
penetration
Yes
Diffuse optical
tomography
Oxy-, deoxy, and total
hemoglobin
Cross-species technique Poor spatial resolution, limited depth
penetration
Yes
Optical imaging
spectroscopy
Oxy-, deoxy, and total
hemoglobin
Combination of good temporal and
spatial resolution, easy to combine
with other techniques
Limited depth penetration, cortical
surface only
Intraoperative
only
Photoacoustic
tomography
Oxy-, deoxy, and total
hemoglobin,
microcirculation
Whole brain imaging, high spatial
resolution
Relatively low temporal resolution No
Optical coherence
tomography
Blood flow
(microcirculation)
Absolute measurement of flow,
good depth penetration and spatial
resolution
Only cortical (surface structure)
imaging possible
No
Laser speckle contrast
imaging
Blood flow (2D) High sensitivity, can image through
skull
Limited depth penetration, spatial
resolution lower then optical
techniques
No
Confocal microscopy Blood flow, tissue
oxygen, microcirculation,
cellular activity
Excellent spatial and temporal
resolution, can measure neuronal
and vascular markers
Loss of spatial resolution at depth,
higher risk of photobleaching
No
Two-photon microscopy Blood flow, tissue
oxygen, microcirculation,
cellular activity
Highest spatial and temporal
resolution, neuronal and vascular
markers, good depth penetration
Relatively costly, not easy to
combine with other techniques
No
Voltage sensitive dye
imaging
Cellular activity High spatial and temporal resolution
measurement of cellular activity
Difficult to combine with other
optical readouts, risk of toxicity from
dyes
No
Laser doppler
flowmetry
Blood flow (point
mesaurement)
Easy to combine with other
techniqies
Point measurement only No
Tissue oxygen
voltammetry
Tissue oxygen (point
measurement)
High temporal resolution Point measurement only, limited
spatial precision
No
Tissue oxygen
polarography
Tissue oxygen (point
measurement)
Very high resolution recording Point measurement only, fragile
electrodes
No
Tissue oxygen
luminescence
Tissue oxygen (point
measurement)
Easy to use, good temporal
resolution
Point measurement only, limited
spatial precision
No
Invasive
electrophysiology
(Various)
Single or multi-unit
activity, local field
potentials
Highly localised recording, optimal
temporal resolution
limited compatibility with fMRI, risk
of damage to brain tissue from
electrode
No
Non-invasive
electrophysiology (EEG,
MEG)
Event-related potentials,
current sources and sinks
High temporal resolution, low cost
human neuroimaging
Limited spatial resolution Yes
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around this (e.g. Huttunen et al., 2008), it is technically challeng-
ing and often requires substantial “development time” on anMRI
system, making it a costly process. Thirdly, there are also limits
to temporal and spatial resolution of PET and to a lesser extent
fMRI. Although high-field strength fMRI is now able to achieve
impressive results, as discussed further below, convergence upon
the spatiotemporal scales at which neuronal activity operates or
blood flow is directly regulated, remains elusive. Finally, a major
barrier to the use of non-invasive imaging techniques for research
in this field is cost: preclinical MRI facilities (for rats/mice) may
charge >$3000 per day, whereas facility costs are typically an
order of magnitude lower for using many of the alternate in vivo
approaches as summarized in Table 1.
OPTICAL METHODS FOR IMPROVED RESOLUTION AND MULTIMODAL
DATA ACQUISITION
Because of these limitations, and because more invasive
approaches can be used in experimental animals models, meth-
ods of making hemodynamic measurements that require more
direct brain access have become well established. An increas-
ingly wide range of techniques make use of the light absorption
and/or scattering properties of brain tissue, and specifically the
hemoglobin present in the vascular system, in order to obtain
high spatial and temporal resolution readouts of hemodynamic
changes. These techniques usually require visualization of the
brain either through a craniotomy or a thin cranial window (the
skull is thinned to translucency over the imaged brain tissue).
One popular technique, intrinsic signal optical imaging (Malonek
and Grinvald, 1996), measures changes in the concentration of
oxy- and deoxy-hemoglobin and is able to resolve changes at
the level of 10 s of microns and 10 s of milliseconds (Figure 3).
This technique is particularly amenable to combination with
other methods, such as the implantation of microelectrodes
to simultaneously record neuronal activity, or the addition of
other probes to record blood flow changes or tissue oxygena-
tion. Another advantage of this approach is that the cost and
complexity of the imaging system is much reduced compared
to MRI systems. However, a major disadvantage of many stan-
dard optical imaging approaches is the limited depth penetration
due to light scattering and absorption by tissue: systems exploit-
ing light in the visible wavelength range are limited in signal
acquisition to just the first few hundred microns of cortical tis-
sue. The related techniques of near infrared spectroscopy which
uses light at longer wavelengths to penetrate several centimeters
of tissue, or diffuse optical tomography which uses an EEG-style
array of detectors (and sources), have the advantage that they
are used in both human and animal studies (they can pene-
trate the skull), but there is a severe trade off in terms of spatial
resolution due to light scattering effects. This class of method-
ologies provides information relevant to both parametric and
physiological neurovascular coupling approaches (although typ-
ically individual research studies will emphasize one other the
other approach). This is because fairly detailed measurement of
different aspects of the hemodynamic and neuronal responses
can be combined with pharmacological manipulations to enable
interrogation of relevant biochemical pathways (e.g. see reviews
by Carmignoto and Gomez-Gonzalo, 2010; Cauli and Hamel,
2010).
FIGURE 3 | Grid-like arrangement of the rodent facial whiskers (A) is
topographically preserved with mapping in somatosensory cortex (B) of
individual whiskers to individual cortical columns (C). (A–C) adapted from
Chen-Bee et al. (2012). (D)Measurement of total hemoglobin concentration
changes during stimulation of individual whiskers (A1–E1) produces
spatiotemporal activation maps that allow spatial discrimination of activation
primarily located in each corresponding cortical column. (E) Co-registered
surface (vasculature) and cortical histological sectionswith the stimulated barrel
highlighted in black to verify anatomical specificity. The contour around each
stimulated barrel is the activated total hemoglobin region defined as all pixels
with 50% of the peak response from a mean image of the last 4 s of the 16 s
stimulation period. (D,E) adapted with permission from Berwick et al. (2008).
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MICROSCOPY METHODS FOR CELLULAR LEVEL RESOLUTION AND
RESEARCH INTO MECHANISMS
Two-photon laser scanning microscopy (2PSLM) in an increas-
ingly popular technique that is able to record both neuronal and
hemodynamic events at cellular level resolution (see Shih et al.,
2012a, for an excellent recent review) thus enabling physiological
neurovascular coupling to be investigated. Fluorescent reporter
molecules are used to provide information about intracellular
events, vascular responses, blood flow and other phenomena and
these can be measured at extremely high spatial resolution due
to the very narrow focal plane of 2PLSM. Additionally, the use
of laser light with wavelengths in the near infrared range is able
to achieve better tissue penetration than standard optical imaging
techniques (up to 1mm). It is also possible to “stimulate” neu-
rophysiological events, for instance using calcium uncaging by
photolysis (e.g. Takano et al., 2006), thus providing opportunities
for very fine levels of control and recording of neurovascular func-
tion. This microscopic approach is often combined with highly
specific pharmacological or electrophysiological manipulations
which may be applied to individual cells. It can be performed
in vivo or in vitro, and increasingly research groups will deploy
the technique in both modes to address a specific question in
order to combine the enhanced control, manipulation and data
quality advantages of the in vitro approach with the demonstra-
tion of functional relevance that is best achieved in vivo. 2PLSM
is therefore becoming established as a “gold standard” method for
addressing physiological neurovascular coupling research ques-
tions. Disadvantages of 2PLSM include the requirement for the
lens objective to be very close to the imaged tissue sample, mak-
ing the combination of 2PLSM with other recording methods
technically challenging. This could be a problem for relating the
microscopic findings from 2PLSM to the more macroscopic vas-
cular and neuronal events that neuroimaging measures or makes
inferences about, respectively, and which is typically a strength of
parametric neurovascular coupling approaches.
MONITORING NEURONAL ACTIVITY
A major advantage of using animal models in this context is
that it is possible to combine methods that measure hemody-
namic changes (including non-invasive imaging tools such as
small animal MRI) with other, usually invasive methods that
can measure the changes in neuronal activity that underlie the
hemodynamic events. For this latter purpose, electrodes can be
implanted directly into the brain to record the activity of neu-
rons and in some cases multi-site electrode probes are used which
can capture activity at multiple locations in the brain or along the
length of a functional unit such as the cortical column (Berwick
et al., 2008). From these recordings it is possible to resolve both
local field potentials (LFPs) (an aggregate measure of excita-
tory and to a lesser extent inhibitory synaptic, activity in a local
cell population, primarily reflecting input) and spiking activity
(action potentials, primarily reflecting output activity). Other,
optical approaches, are able to produce high resolution 2 or 3-D
maps of cellular activity (Akkin et al., 2010), often in combi-
nation with reporter dyes (Devor et al., 2007). Although these
invasive approaches provide measurements of neuronal activity
that share signal sources with non-invasive electrophysiological
techniques that are used in human subjects, such as EEG orMEG,
because of large differences in the spatial resolutions achievable
and other factors, direct comparisons are not straightforward.
In this respect, further research is needed to improve under-
standing of the relationships between the different measures of
neuronal activity made in humans and animal models to under-
pin translation of findings between studies (e.g. Buzsáki et al.,
2012).
The direct brain access, experimental control and stability
afforded by the use of experimental animal models has enabled
many combinations of the techniques or approaches described
above and in Table 1 to be used in order to directly interro-
gate neuroimaging signals and neurovascular coupling (see Zhao
et al., 2014c). For example, in our own laboratory we have estab-
lished concurrent optical imaging and high field fMRI in rodents
in order to provide insights into the hemodynamic constituents
of BOLD fMRI signal changes (Figure 4). Working outside of
the MRI environment we have been able to combined a wider
range of measurement techniques for concurrent recording of
various neuronal, metabolic, and hemodynamic signals in rodent
somatosensory cortex (Figure 5), providing a multimodal read-
out of neurovascular function. The multimodal measurement
techniques, when combined with other experimental tools such
as transgenic animals or pharmacological manipulations, can
FIGURE 4 | Concurrent fMRI and optical imaging spectroscopy. An
oblique slice covering the dorsal surface of the brain (top left) is first used to
identify a coronal (top center) or topographic slice (top right) containing the
whisker barrel cortex for fMRI data acquisition. Apparatus allowing
concurrent optical imaging is illustrated (top), consisting of a specially
adapted MRI-compatible endoscope to transmit light to and from the brain
surface. Optical imaging data is shown in the bottom panels, including the
raw gray scale imaging of the cortical surface visualized through a thin
cranial window (left and center), and activation induced changes in
deoxyhemoglobin concentration (right) that correspond well to the
concurrently acquired fMRI data (top right). Adapted with permission from
Kennerley et al. (2012).
Frontiers in Neuroscience | Brain Imaging Methods August 2014 | Volume 8 | Article 211 | 6
Martin In vivo neuroimaging research insights
FIGURE 5 | Example of concurrent multi-modal measurement of
neurovascular function developed in our laboratory showing
simultaneously acquired neuronal, metabolic and vascular responses in
the somatosensory cortex following a 16 s stimulation of the
contralateral whisker pad. (A) Cerebral blood volume (CBV) activation map
from optical imaging spectroscopy (OIS). (B) Grayscale image of thin cranial
window with measurement probes indicated. (C) Neuronal response (LFP
shown). (D) Oxy/Deoxy/Total Hemoglobin changes from OIS with cerebral
blood flow (CBF) changes from laser Doppler flowmetry. (E) Tissue oxygen
and temperature responses.
provide new insights which bridge the “parametric” and “phys-
iological” neurovascular coupling research approaches. This is
especially the case when the resultant data is made available for
the development of biophysical models which attempt to cap-
ture the mathematical relationships between important biological
parameters (e.g. Zheng et al., 2010; Brodersen et al., 2011; Rosa
et al., 2011).
POSSIBILITIES FOR ACUTE AND RELIABLE LONGER TERM DATA
ACQUISITION
Acute experiments involving animal models might be conducted
over many hours, during which time baseline physiological
parameters are carefully monitored and maintained within a nar-
row range. This enhanced window for data acquisition enables a
more intensive exploration of the effects of manipulating inde-
pendent variables (such as stimulation intensity, duration, fre-
quency, repetition rate, multiple stimulus types) upon measured
responses than would be possible in human subjects. Within such
a time window it also possible to explore the effects of phar-
macological or other manipulations on a within-subjects basis,
obtaining neurovascular coupling readouts pre-, during-, and
post-treatment. Because animals can be fixed with respect to
the imaging apparatus more rigidly and for longer periods than
would be possible in human subjects, test-retest reliability is very
high. Chronic experimental designs are also possible where data
from individual subjects can be acquired repeatedly over many
weeks or months (Weber et al., 2006; Silva et al., 2011; Brydges
et al., 2013; Martin et al., 2013). Although such approaches are
also used in human neuroimaging studies, the high degree of
experimental control possible in animal studies is particularly
advantageous in light of the many factors which in humans can
alter neurovascular coupling (e.g. as discussed elsewhere in this
paper).
WHOLE BRAIN ACCESS
Human neuroimaging studies frequently report on responses to
stimuli occurring across the brain, in both cortical and subcortical
regions. In animal models it is possible to elicit controlled changes
in neuronal activity in specific structures, including deep brain
structures, which are not easily accessible to non-invasive stim-
ulation techniques in order to refine our understanding of neu-
rovascular coupling across the whole brain. In addition, as many
brain structures are in receipt of multiple, convergent inputs
that may or may not involve different cell types or neurotrans-
mitters, it is possible, by independently stimulating convergent
pathways, to improve our understanding what the composite neu-
roimaging signal is revealing about input patterns (e.g. see Enager
et al., 2009; Krautwald and Angenstein, 2012; Krautwald et al.,
2013).
KEY AREAS OF INSIGHT FROM IN VIVO EXPERIMENTAL
ANIMAL RESEARCH STUDIES
In the following sections, we focus on four major themes that
emerge from state-of-the-art research studies using animal mod-
els which target key questions in relation to understanding
neuroimaging signals.
HETEROGENEOUS DISTRIBUTION OF fMRI SIGNALS SOURCES
REVEALED BY HIGH FIELD STRENGTH fMRI
Research carried out on high field strength, preclinical MRI sys-
tems has provided important insights into the hemodynamic
composition of neuroimaging signals as well as the localization
of separable signal components to specific vascular or neuronal
architectures across the cortical laminae. This is a question not
just relating to anatomical localization, but given our extensive
understanding of how neural computation is distributed within
the cortical columnar structure, goes to the core of precisely
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“what” fMRI signals reveal about neuronal activity in the context
of cortical neuroimaging.
Recent studies in rodents and non-human primates have
enabled the cortical hemodynamic response to sensory stim-
ulation be elucidated as a function of cortical depth. Goense
et al. (2012) studied both positive and negative BOLD signals,
in addition to the commensurate CBV and CBF changes, in the
primary visual cortex of anesthetized macaques. Although pos-
itive BOLD signals were associated with increases in both CBV
and CBF, the depth profile varied for the BOLD, CBV, and CBF
changes. Whilst BOLD increases were maximal at the cortical
surface, CBF increases were maximal at approximately layer IV
whilst CBV increases occurred with relative uniformity through-
out the cortical layers. More intriguingly, negative BOLD signals
occurred in regions where CBV increased and CBF decreased.
Maximal negative BOLD responses occurred across the middle
cortical layers whereas CBV responses were largest around layer
IV and CBF responses were largest at the surface. This pattern
of results suggest that the hemodynamic response to changes in
neuronal activity that is measured in most neuroimaging studies
(which lack the ability to resolve cortical layers) is an aggre-
gate of a complex set of blood volume, flow and oxygenation
response functions which appear to be heavily dependent upon an
interaction of vascular and neuronal architecture. Goense et al.,
further conclude that these data provide evidence for differing
neurovascular coupling mechanism operating at different cor-
tical layers and underlying positive and negative BOLD signal
changes. These data are in broad agreement with Shih et al. (2013)
who used CBV-weighted fMRI at 11.7T in anaesthetized rats to
resolve hemodynamic changes at a resolution that revealed cor-
tical columnar like structure. CBV changes were again found to
be maximal at ∼layer IV. In this study, the laminar profile of
neuronal activity was also measured (in a separate group of ani-
mals) and this revealed a mismatch between hemodynamic and
neuronal activation-depth profiles. A further challenge to the
specificity of BOLD fMRI signals to neuronal activity at the level
of cortical laminae was reported by Herman et al. (2013), who
calculated the laminar profile of changes in oxidative metabolism
(CMRO2) in response to somatosensory stimulation in anes-
thetized rodents using a multimodal “calibrated fMRI” approach.
Here, BOLD and CBV changes appeared spatially uncoupled to
separately measured neuronal activity whereas CBF and CMRO2
changes were relatively well coupled to LFPs and multi-unit
activity (spiking) respectively.
On the one hand the data obtained using these methods are
problematic for fMRI: the neuronal activity mapping potential
of BOLD signals in particular appears to be confounded by the
neurovascular macrostructure of the cortical column (the spa-
tial relationship of micro- and macro-vasculature to the neuronal
and neurometabolic activity “sinks”). On the other hand, these
data represent a new set of constraints that researchers can build
into mathematical modeling and data analysis tools in order
to improve the accuracy of inferences about neuronal activity.
In addition, the increasing availability of higher field strength
systems for research use and a wider use of multimodal fMRI
acquisition approaches (i.e., acquiring CBF and/or CBV data in
addition to BOLD signals) will mitigate against the uncertainty
inherent in BOLD signals. An important new direction for high
field strength fMRI research will be to improve understanding
of neurovascular and hemodynamic variability across heteroge-
neous subcortical structures, for instance across the thalamus,
hippocampus, or adjacent component structures of the basal gan-
glia. Since fMRI methods can be applied in both human and
animal models, these efforts will be best served by designing stud-
ies that are as far as possible analogous between species (i.e.,
in terms of stimulation paradigms, pulse sequences, anatomical
focus), with animal models presenting an opportunity for more
detailed investigation of key findings using additional, invasive
techniques (as described above).
CHARACTERIZATION OF HEMODYNAMIC IMPULSE RESPONSE
FUNCTIONS (HIRF)
The “hemodynamic impulse response function” (illustrated in
Figure 2) is widely used as a canonical model in fMRI data anal-
ysis tools and as such a detailed understanding of this and how
this is affected by brain region, health and disease status, phar-
macological or physiological manipulations, is very important
(Gitelman et al., 2003; Martindale et al., 2003; Handwerker et al.,
2012). In essence, the HIRF refers to the hemodynamic response
that results from a single neuronal event: by convolving this
function with either measured neuronal activity or more com-
monly an estimate of the neuronal input function, an estimate
of the neuroimaging signal change attributable to the stimulus
is obtained. The HIRF is often approximated as a composite
of two gamma functions which may be specified by a relatively
small number of parameters. In fMRI analysis these parame-
ters can either be fixed or allowed to vary within a predefined
range in order to optimize the identification of responsive voxels.
Although the general form of the temporal HIRF has been well-
characterized and there is recent evidence that it is stable in the
context of robust alterations in hemodynamic baseline param-
eters (Kennerley et al., 2012), in human studies as well as in
animal experiments it has been shown that there are many fac-
tors that can influence the parameter values that specify the HIRF
(Figure 6), as reviewed by Handwerker et al. (2012). A further
complication is introduced by Hirano et al. (2011) who argue that
a discrepancy between the BOLD and CBF HIRF that becomes
apparent whenmoving from very brief to longer stimuli, is related
to differential contributions of venous and arterial hemodynamic
changes to the neuroimaging signals at different time points.
Even less well-understood is the spatial structure of the HIRF,
yet specification of this is equally important in the context of
spatiotemporal neuroimaging methods and the signal processing
required. Within the cortex, the distinct neuronal and vascular
architecture that is present in different layers is known to be a
source of variability in hemodynamic responses, as described in
the previous section. There have however been very few exper-
imental studies investigating the spatial relationships between
neuronal and hemodynamic signal changes across the cortical
surface or in sub-cortical structures. One exception is Vazquez
et al. (2013), who investigated the hemodynamic point-spread
function using a multimodal stimulation and data-acquisition
approach and showed a linear relationship between the spatial
extent of neuronal and hemodynamic responses. One reason for
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FIGURE 6 | Potential modulators of the neuronal-neuroimaging signal
relationships illustrated in Figure 1. When considering two neuroimaging
targets, which may be: (1) different brain regions, (2) the same region in
different subjects, (3) the same region in the same subject at different time
points, or (4) the same region with before and after an experimental
manipulation, it is important to consider the many possible differences
between these targets that might affect the relationship between the
measured hemodynamic and the inferred neuronal events.
a lack of research into the spatial correspondence of neuronal and
hemodynamic changes that is required to inform development of
a spatial HIRF is the availability of methods to simultaneously
provide spatiotemporal readouts in bothmeasurementmodalities
(e.g. see Baraghis et al., 2011). One solution is to investigate spa-
tial hemodynamic changes in the context of neural systems with
very well-known spatial response properties, such as the primary
visual cortex (e.g. Aquino et al., 2014). In the context of optical
imaging techniques it may also be possible to take advantage of
rapid changes in light scattering that occur (due to cell swelling)
when neurons are activated, or to separate optical signal compo-
nents (e.g. from intrinsic metabolic and hemodynamic markers)
using multichannel acquisition systems (Zhao et al., 2014b).
In section Relating signals in time and space, we review other
research into the temporal and spatial relationships between neu-
ronal and hemodynamic signal changes which will also be impor-
tant in the refinement of the canonical HIRF and how it is used.
Understanding the sources of HIRF variability could lead to
improvements in neuroimaging experimental design, data analy-
sis or interpretation. This understanding could also produce pos-
sibilities for differences in the HIRF to be exploited as biomarkers
for the neuronal, vascular, or neurovascular perturbations of
function associated with many brain diseases. Future goals could
include the development a framework for neuroimaging data
analysis that applies empirically derived constraints on a flexible
HIRF according to (e.g.) brain region, subject age, health status,
etc. Alternately, methods for obtaining subject or brain region
specific HIRF estimates in human neuroimaging could be investi-
gated (Kang et al., 2003; Handwerker et al., 2012) with the aim of
developing a rapid scanning protocol which can help “tune-up”
the canonical HIRF to be used in the analysis of the main study
neuroimaging data.
INVESTIGATIONS OF NEUROVASCULAR COUPLING MECHANISMS
A full review of insights into the biochemical or physiologi-
cal mechanisms known to underpin neurovascular coupling is
beyond the scope of this paper and there are a number of excellent
recent reviews which address this issue directly (e.g. Attwell et al.,
2010; Carmignoto and Gomez-Gonzalo, 2010; Cauli and Hamel,
2010; Hillman, 2014). In overview, combining the methodolo-
gies detailed in section Investigating neuroimaging signals using
experimental animal models and Table 1 with pharmacologi-
cal manipulations has been useful in elucidating, for instance
through selective inhibition, key mechanisms, molecules, and
mediators involved in neurovascular coupling. It is partly through
this approach for instance that the roles of nitric oxide (Akgoren
et al., 1994; Lindauer et al., 1999; Kitaura et al., 2007) and
cyclooxygenases (Niwa et al., 2000, 2001; Lecrux et al., 2012) in
neurovascular coupling have been elucidated, or the relationships
between cerebral blood flow changes and oxidative metabolism
have been probed (Leithner et al., 2010). This approach also
enables the impact of therapeutic or other drugs upon neurovas-
cular coupling or brain imaging signals to be investigated, either
to explore these effects directly or to inform fMRI data interpreta-
tion in (for example) patient groups (Choi et al., 2006; Lindauer
et al., 2010; Chin et al., 2011; Sander et al., 2013).
Most recently, possibilities for using optogenetic tools to help
dissect the cellular-specific contribution to BOLD signals and
neurovascular coupling have become available. Work using these
methods is in its earliest stages. It has been applied to investi-
gate the spatial correspondence of hemodynamic and neuronal
responses to light-activation vs. sensory stimulation (Vazquez
et al., 2013; Li et al., 2014) and in addition Lee et al. (2010) com-
bined optogenetic stimulation with fMRI in mice and demon-
strated a complex pattern of both positive and negative BOLD
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signal changes attributable to specific activation of cortical pyra-
midal cells (Lee et al., 2010; Urban et al., 2012). As in other areas
adopting optogenetic approaches, there is a proliferation of new
viral vectors and transgenic lines that allow targeting of specific
components parts of the overall system (for example, astrocytes,
Figueiredo et al., 2011) and as such it seems likely that these
approaches will provide important insights into the contribu-
tions of elements of the neurovascular “circuit” to hemodynamic
and fMRI signal changes. Whilst there are a finite number of cell
types which contribute to neurovascular coupling, the number
of pharmacological components of the key signaling pathways is
much larger and by way of their interactions, substantially more
complex. Combining new optogenetic tools and in particular
inhibitory techniques (e.g. via halorhodopsin) with pharmaco-
logical manipulations will perhaps provide the most important
insights, as this will allow interrogation of cell-specific biochem-
ical pathways. It should also be noted that hemodynamic signal
changes, and in particular when detected using fMRI, may be
vulnerable to localized heating effects caused by laser power, as
recently reported by Christie et al. (2012) and as such the use of
optogenetic tools in neurovascular research will require careful
validation.
A long standing debate in the literature which has recently
become more prominent and which is likely to benefit from the
development of optogenetic tools, concerns the relative contri-
butions of neurons, astrocytes, and pericytes to neurovascular
coupling. Whilst the release of neurotransmitters and vasoactive
molecules from neurons is well established as a primary factor in
initiating vascular responses, how to attribute the subsequent bio-
chemical cascade resulting in locally increased blood flow to spe-
cific molecules and cell types remains uncertain. On the one hand
a recent paper provided evidence for stimulus induced vasodila-
tion occurring independently of the astrocyte-located mechanism
thought to be critical for initiating the blood flow response (Nizar
et al., 2013), yet conflicting results were subsequently reported by
Lind et al. (2013). For an in-depth review of the complex role of
astrocytes in neurovascular coupling, see Howarth (2014). Two
very recent publications are likely to initiate new lines of enquiry
in this field. Firstly Hall et al. (2014) outline a major and previ-
ously neglected role for pericytes in highly localized and dynamic
control of blood flow in the brain and in a review Hillman (2014)
suggests vascular endothelial cells may represent an additional
overlooked mechanism in the regulation of brain blood flow and
the generation of neuroimaging signals. The increasingly appar-
ent complexity of neurovascular coupling may suggest a degree of
physiological redundancy in the regulation of brain blood flow, an
evolutionary consequence of the very limited oxygen available for
sustaining the brains high metabolic demand should blood flow
be perturbed. A finding by Leithner et al. (2010) that 30% of the
hemodynamic response to evoked neuronal activity remains even
when the major known biochemical pathways mediating neu-
rovascular coupling are simultaneously inhibited by a cocktail of
pharmacological agents, and that this reduction had little impact
on neuronal activity, certainly seems indicative of system about
which there is much to discover.
These uncertainties are important for the interpretation
of neuroimaging signals in a number of ways. Knowing
the biochemical or cellular substrates of hemodynamic signal
changes, the relative contributions of direct neuron-vascular sig-
naling pathways or signaling mediated via other cell types, will
provide basic insights into the information contained within
neuroimaging signals about (for example) neural computa-
tion or functional connectivity. Furthermore, variation in the
contribution or functioning of these pathways between brain
regions, disease states, age, and many other conditions could
alter the provision of such information, and therefore have
implications for how we interpret neuroimaging data in many
situations.
In summary of this section, research into neurovascular
coupling and the neurophysiological basis of neuroimaging sig-
nals is advancing beyond a broad-brush validation of neu-
roimaging signals as a marker for neuronal activity changes.
It is now detailing a wider empirical landscape that will be
needed for the interpretation of functional brain imaging sig-
nals acquired in increasingly diverse experimental and empir-
ical contexts. The next sections highlight research in these
areas that challenges simplistic interpretations of fMRI signals,
suggesting that a more nuanced and contextually informed
approach to signal analysis and data interpretation is indeed now
required.
INTERPRETING FUNCTIONAL BRAIN IMAGING SIGNALS AS
NEURONAL ACTIVITY
In Figure 6 we summarize the factors which may influence what
neuroimaging signals tell us about neuronal activity and which
may differ between many conditions including brain regions,
subjects, patient groups, and time-points. With respect to the
interpretation of functional MRI signals, neuronal activity is usu-
ally broadly classified into two types: LFPs or spiking activity.
Much research and discussion has focused upon the relative con-
tributions of these two types of activity to BOLD signals and
although it is generally recognized that neuroimaging signals cor-
relate best to LFPs (Logothetis et al., 2001; Viswanathan and
Freeman, 2007), spiking activity has also been shown to correlate
closely in many (Logothetis et al., 2001; Jones et al., 2004), but not
all contexts so far investigated (Caesar et al., 2003; Thomsen et al.,
2004; Rauch et al., 2008). Another question that has been exten-
sively investigated using experimental animals is whether brain
hemodynamic responses are linearly, or non-linearly related to
changes in specific aspects of neuronal activity. Research in which
simultaneous neuronal and hemodynamic measures are made
in cortex has shown that both linear and non-linear patterns of
coupling are found which may be attributable to a range of fac-
tors (Jones et al., 2004, 2008; Sheth et al., 2004; Hewson-Stoate
et al., 2005; Martin et al., 2006b; Hoffmeyer et al., 2007; Zhang
et al., 2009; Liu et al., 2010; Magri et al., 2011). The issues of lin-
earity and contributions of spiking or synaptic activity become
more complex when the relative contributions of different neu-
ronal input pathways (e.g. Enager et al., 2009) and neuron types
to neurovascular coupling are considered. For example, it has
been shown that both excitatory (glutamatergic) and inhibitory
(GABAergic) neurons can evoke positive BOLD signals, whilst
activity amongst inhibitory neurons alone can produce negative
BOLD signals (Lauritzen et al., 2012).
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It is important to note that much of the research that has
been conducted to investigate the relative contributions of neu-
ronal activity types to neuroimaging signals has focused almost
exclusively on cerebral and to a lesser extent cerebellar cortical
structures. Human neuroimaging on the other hand, is applied
to study the whole brain and signals originating from subcorti-
cal structures are tacitly interpreted in the same way as cortical
signals, despite the relative lack of empirical research to support
such an approach. Indeed, the research that has been conducted
suggests that neurovascular coupling is brain region dependent
(Sloan et al., 2010; Devonshire et al., 2012), a finding that is per-
haps not unsurprising given we know that brain structures differ
substantially in their cytoarchitecture, vascular density, involve-
ment of different neurons and neurotransmitter systems, and
other factors (see Figure 6). We argue that as human neuroimag-
ing continues to provide surrogate markers for activation across
the whole brain, experimental animals studies will be needed to
probe the regional heterogeneity of neurovascular coupling and
the relative contributions of the various components of neuronal
activity. Key questions to ask of specific brain structures include:
• What types of activity, in which neurons and under the influ-
ence of which efferent inputs are represented in fMRI signals?
• Are the “activation” thresholds for functionally meaningful
neuronal activity (e.g. as determined through behavioral assay)
and fMRI detectable hemodynamic changes equivalent?
• What are the baseline or resting state characteristics of neu-
ronal activity, metabolism or hemodynamics upon which
experimentally evoked changes are superposed?
RELATING SIGNALS IN TIME AND SPACE
Detailed investigation of the spatiotemporal evolution of the
hemodynamic response in experimental animal models has
demonstrated that as it propagates through the capillary net-
work and begins to include lager contributions from upstream
or downstream changes in arterioles and venules respectively,
the estimation of neuronal signal changes from hemodynamic
proxies inevitably becomes more difficult (Hirano et al., 2011;
Yu et al., 2012). For instance a recent study investigated the
spatial correlation between neuronal activity and fMRI BOLD
responses in the mouse somatosensory cortex using a combi-
nation of sensory stimulation and channelrhodopsin-mediated
activation (Li et al., 2014). Focal activation of neurons using
laser light produced neuronal responses that were tightly con-
fined to the area of stimulation (∼0.5mm), whereas the hemo-
dynamic responses to the same stimulus extended to a much
larger area (>3mm). Work by Vazquez et al. (2013) indicates
a closer spatial correspondence of neuronal and hemodynamic
changes where hemodynamics are measured using optical meth-
ods. This highlights how the ability of BOLD fMRI to spatially
resolve neuronal activity changes is in part limited by biophys-
ical factors such as large-vessel signal contributions to BOLD
signals (see Kim and Ogawa, 2012, for a full review). In any
case, it is evident that measuring the fine detail of the hemo-
dynamic point-spread function, which may itself depend upon
various factors (Figure 6), is important for mapping neuronal
events.
Inverted hemodynamic responses corresponding to negative
BOLD signal changes have also been studied in detail in ani-
mal models using optical imaging techniques. In both awake and
anaesthetized rats, a center-surround response profile has been
observed, where focal increases in cerebral blood flow, volume
and oxygenation are accompanied by an inverted response annu-
lus which itself appears to have a neuronal origin (Devor et al.,
2007; Boorman et al., 2010; Martin et al., 2012). Although these
“negative surround” responses are detectable using high field
strength small animal fMRI (Kennerley et al., 2012), it is less likely
that these small changes would be readily detectable in human
fMRI, even though they may represent an important component
of the overall response. The equivalent problem may also exist
in the temporal domain. Our own work in awake rodents has
revealed that the temporal hemodynamic responses function may
have additional complexity which is masked by the commonplace
us of anesthesia in in vivo research studies (see Discussion below
and Martin et al., 2013). Specifically, we find evidence for a more
dynamic, oscillatory hemodynamic response in cortex yet once
again the limitations of (in this case temporal) resolution in typi-
cal human fMRI would make it unlikely that such changes would
be detected (Martin et al., 2013). A recent theoretical work sup-
ports both of these empirical results, predicting the occurrence
of both an adjacent region of negative BOLD response as well as
temporal signal oscillations (Aquino et al., 2014).
Improvements in our understanding of the fine detail of the
spatiotemporal hemodynamic response function would have two
main benefits. Firstly, by enabling the derivation or estimation of
a more accurate spatiotemporal HIRF (e.g. one that accounts for
spatiotemporal hemodynamic oscillations, Aquino et al., 2014),
we would be better able to estimate the magnitude and spa-
tial extent of the underlying neuronal responses in standard
fMRI studies. Secondly, as the spatial and temporal resolution
of neuroimaging increases with greater availability of higher field
strength magnets and other technological improvements, deter-
mining the finer grain detail of the spatiotemporal HIRF becomes
more important to ensure parallel improvements in the accuracy
of mapping neuronal activity in space and time using hemo-
dynamic proxies. In both cases, it is clear that more research
is needed to determine the spatiotemporal correspondence of
hemodynamic responses to underlying neuronal activity, as well
as how this changes across the brain.
QUANTIFICATION, BASELINES, AND NEUROENERGETICS
A major limiting factor for the interpretation of neuroimaging
signals, especially those studies using BOLD fMRI, is the fact
that BOLD signal changes are not quantitative. Signal changes are
expressed as a percentage of baseline values which are themselves
known to be influenced by a wide range of neurophysiological
and general physiological factors. Because the BOLD signal is a
product of cerebral blood flow, cerebral blood volume, and oxy-
gen consumption (Figure 1), baseline changes affecting any or
all of these properties will impact upon measured BOLD signals
in ways that may not necessarily reflect commensurate changes
in neuronal activity. For example, commonly ingested substances
such as caffeine can alter BOLD baseline, in part through effects
on oxidative metabolism and cerebral blood flow (Mulderink
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et al., 2002; Griffeth et al., 2011), as can aging, disease, or a
range of pharmacological manipulations (e.g. D’esposito et al.,
2003; Iannetti and Wise, 2007). In addition, Jones et al. (2008)
showed that experimental alterations in baseline neuronal activity
intended to emulate switching between different cortical arousal
states affected neurovascular coupling in a rodent model. As dis-
cussed in section Limitations of animal models for neurovascular
research, a major concern for the use of animal models in this
field is the effects of anesthetic agents on baseline parameters.
One approach to tackling these difficulties has been to develop
calibrated fMRI methods for use in humans which are able to
provide quantitative measures of metabolic changes in response
to task or stimulus conditions (see review by Hoge, 2012). This
approach effectively reduces the uncertainty inherent in standard
fMRI studies by providing a measurement that is more directly
linked to neuronal activity changes, moving the research imper-
ative from neurovascular coupling to neurometabolic coupling
and neuroenergetics. Research in experimental animal models is
making important contributions in this area and this endeavor is
supported by recent evidence that the brain’s energy budget, that
is the attribution of brain energy consumption to different neu-
ronal processes (Attwell and Laughlin, 2001), is preserved across
mammalian species (Hyder et al., 2013). A full review of neu-
rometabolic coupling and neuroenergetics is beyond the scope of
the present paper (see Hyder and Rothman, 2012), however an
important early finding from studies in rat was that energy use
by neurons (oxidative glucose consumption) is linearly correlated
to excitatory neuronal activity (glutamate release, Sibson et al.,
1998). Understanding the relationship between oxidative glu-
cose consumption and specific components of neuronal activity
is therefore an important objective for interpreting quantitative
neuroimaging signals. It is partly because of this and the knowl-
edge that the metabolism of neurons and astrocytes is closely
related (e.g. Pellerin and Magistretti, 1994; Bélanger et al., 2011),
that research to understand the fine detail of neuron-astrocyte
communication is so important for understanding functional
brain imaging signals. Studies in which the activity of neurons
and astrocytes can be differentiated and/or specifically manipu-
lated, for example using optogenetic approaches combined with
2PLSM will be significant in this regard (Li et al., 2013a) and
combination of these approaches with metabolic readouts, for
instance using molecular oxygen sensors (Lecoq et al., 2011) or
more macroscopic techniques (e.g. see Devor et al., 2012) will
advance understanding considerably.
IMPACT OF DISEASE AND MODULATORY
NEUROTRANSMITTERS UPON THE INTERPRETATION OF
FUNCTIONAL BRAIN IMAGING SIGNALS
Functional brain imaging is increasingly being applied to inves-
tigate brain function in clinical populations (e.g. Diamond et al.,
2007; Karmonik et al., 2010; O’brien et al., 2010; Sundermann
et al., 2014), it is important to be able to conduct a detailed
exploration of the impact of brain diseases upon neuroimag-
ing signals and their relationship to neuronal activity in animal
models. This includes the use of both transgenic lines and phar-
macologically or surgically induced disease states (Sanganahalli
et al., 2013; Serres et al., 2014). Such investigations may become
more important as neurovascular breakdown becomes increas-
ingly implicated in a range of disease conditions (Zlokovic,
2010, 2011), suggesting that the empirical basis of assumptions
concerning neuroimaging signal interpretation which have been
established through research primarily in healthy animals, may
not apply. If neuroimaging techniques are to be used to investigate
the effects of therapeutic drugs on brain function biomarkers, it
will also be important for example to delineate (neuro)vascular
and neuronal effects of these drugs. For example, a study in
human Alzheimer’s patients suggested that acetycholinesterase
inhibitors produced alterations in cortical vascular response to
stimuli that were independent of changes in the underlying neu-
ronal response (Rosengarten et al., 2009). In addition, the impact
of other perturbations of normal brain function including nor-
mal aging (D’esposito et al., 2003; Rosengarten et al., 2003) and
the ingestion of substances known to alter neurovascular and/or
hemodynamic function such as caffeine (Pelligrino et al., 2010;
Diukova et al., 2012) or alcohol (Luchtmann et al., 2013) upon
these signals can also be explored in depth (Meno et al., 2005;
Diukova et al., 2012).
Because functional brain imaging signals are the final conse-
quence of neuronal, neurometabolic and hemodynamic events,
they are vulnerable to disease-related perturbations operating at
a number of levels. Although alterations in neuronal function as
a result of pathology are in general likely to be reflected within
altered neuroimaging signals, a key question however is to what
extent these signal changes also reflect alterations in the nor-
mal translation of neuronal events to hemodynamic changes?
The use of neuroimaging data to estimate differences in neural
signals within subjects, between groups or experimental condi-
tions, or across experimental animals, tacitly assumes preserved
or at least non-systematically altered neurovascular coupling.
There is however accumulating evidence that many brain diseases
feature altered neurovascular coupling and that in estimating
neuronal signals using hemodynamic based imaging techniques,
these effects must be taken into account.
NEUROIMAGING IN NEURODEGENERATIVE DISEASE
There is a growing consensus that changes in the function of
the neurovascular unit are a critical component of brain dis-
ease development and progression (Benarroch, 2007; Zacchigna
et al., 2008; Iadecola, 2010; Grammas, 2011; Zlokovic, 2011). In
the case of neurodegenerative disease, alterations in neurovas-
cular function have been detected at early stages, preceding the
onset of clinical indicators (Bookheimer et al., 2000; Ruitenberg
et al., 2005; Knopman and Roberts, 2010; Sheline et al., 2010;
Zlokovic, 2011) and it is now well established that cerebrovas-
cular dysfunction is a major risk factor for many brain diseases
(Girouard and Iadecola, 2006; Iadecola, 2010; Toledo et al.,
2013). A number of studies have identified changes in vascu-
lar reactivity, hemodynamic responses or neurovascular coupling
in animal models of neurodegenerative disease (Rancillac et al.,
2012; Sanganahalli et al., 2013). In relation to this, neuroinflam-
mation has been identified as a key neurodegenerative disease
process involving neurovascular unit disruption. Whilst acute
neuroinflammatory responses may have a neuroprotective func-
tion, chronic inflammatory responses within the central nervous
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system are associated with neuronal damage and may not only
“fans the flames” of many CNS disorders (Frank-Cannon et al.,
2009), but may precede and even play a causal role in these dis-
eases (Hauss-Wegrzyniak et al., 1998; Qin et al., 2007; Gao et al.,
2011; Cunningham, 2013).
Work carried out in specific animal models of disease has
also suggested disease-related alterations in neurovascular func-
tion that may affect our ability to interpret fMRI signal changes.
In the area of neurodegeneration for instance, a widely used
transgenic model is one in which the amyloid-beta precursor
protein (APP) is over-expressed, leading to a toxic accumula-
tion of amyloid-beta protein. Such models recapitulate many,
but not all (for a review see Balducci and Forloni, 2011) of the
major features of human AD including an age-dependent neu-
rovascular impairment and vascular dysfunction (Lecrux and
Hamel, 2011). Work in these mice shows, amongst other things,
impaired hemodynamic responses to neuronal activation, altered
resting cerebral blood flow and cerebrovascular autoregulation
and impaired metabolic activity (Iadecola et al., 1999; Niwa et al.,
2002; Nicolakakis et al., 2008). Additionally, ApoE4 mice model
the known association in humans between AD (and cerebral
amyloid angiopathy, CAA) and possession of the apolipoprotein
E ε4 allele (ApoE4). Expression of ApoE4 has been linked to
higher risk of AD with earlier onset (Blacker et al., 1997) and
is believed to be related to dysfunctional clearance of amyloid-
beta from the brain (Castellano et al., 2011; Hawkes et al.,
2012). It has been suggested that the APOEε4 allele may alter
neurovascular function through amyloid-beta exerting a time-
and concentration-dependent toxic effect on rat microvascular
endothelial cells (Folin et al., 2006). In addition, fMRI readouts
of brain hemodynamic signals have found that in human ApoE4
carriers, cerebral blood flow, task-related brain activity, and func-
tional connectivity appear altered several decades prior to any
clinical indicators of dementia (Filippini et al., 2009, 2011).
In addition to Alzheimer’s disease and other neurodegenera-
tive conditions, alterations in neurovascular coupling have also
been reported in a number of other diseases and pathologi-
cal states (Girouard and Iadecola, 2006; Hamilton et al., 2010)
including stroke and ischemia (Lin et al., 2011; Baker et al., 2013;
Jackman and Iadecola, 2014), hypertension and hypotension,
spreading depression (Hamzei et al., 2003; Nagaoka et al., 2006;
Del Zoppo, 2010; Ayata, 2013; Fordsmann et al., 2013) as well as
in normal aging (D’esposito et al., 2003). There is also accumulat-
ing evidence for longer term effects of systemic health challenges
upon brain microcirculatory regulation and neurovascular cou-
pling. For example, a recent study demonstrated impairment of
neurovascular coupling in animals fed a high fat diet over a
period of several weeks (Li et al., 2013b) and systemic infection
has been show to produce alterations in cerebrovascular function
(Puntener et al., 2012) and the shape of hemodynamic responses
(Couch et al., 2013). Finally, many brain diseases involve alter-
ations in the function of specific neurotransmitter systems, and
we refer the reader to the next section for an exploration of the
possible effects of such alterations.
Overall, there is substantial scope for disease conditions and
potentially the health status of individuals more generally to
impact upon how we should interpret functional neuroimaging
data. By understanding more specifically how these alterations
impact upon neurovascular function and the relationships
between neuronal and hemodynamic changes, it may be pos-
sible to either optimize data analysis strategies to account for
these effects or build consideration of these changes into our
discussions of neuroimaging findings. Lastly, we speculate that
early alterations in neurovascular function associated with many
diseases may be detectable through concurrent measurement of
neuronal and hemodynamic activity in the brain. As such, these
neurovascular changes may provide for novel disease biomarkers,
measureable usingmultimodal techniques that are now becoming
available for use in humans. We return to this in the last section
of this review.
NEUROTRANSMITTER AND NEUROPHARMACOLOGICAL
MODULATIONS OF NEUROVASCULAR COUPLING
Although the established view of the role of specific
neurotransmitters in neurovascular coupling processes empha-
size predominantly glutamate and GABA (e.g. Logothetis, 2008),
recent evidence has emerged suggesting that other neurotrans-
mitters may also play a role. The serotonin, noradrenaline,
dopamine, and acetylcholine systems each feature neurons that
project widely throughout cortical and subcortical structures, in
addition to forming key elements of certain specific structure-
structure connections. A fundamental challenge for the use of
hemodynamic imaging methods in contexts where function in
these neurotransmitter systems (and relevant structures) arises
from the fact that they are vasoactive (Choi et al., 2006; Hamel,
2006; Martin and Sibson, 2008; Jenkins, 2012; Shih et al., 2012b;
Toussay et al., 2013), and therefore able to elicit hemodynamic
effects which may not be directly related to their effects upon
neuronal activity. We will focus here on the emerging evidence
for effects of dopamine and serotonin neurotransmission upon
neurovascular coupling and the interpretation of neuroimaging
signals, although similar lines of evidence exist for modulation
of neuroimaging signals by other neurotransmitters including
acetylcholine (Hamel, 2006; Rosengarten et al., 2006; Kocharyan
et al., 2008) and noradrenaline (Toussay et al., 2013).
The neurotransmitter dopamine (DA) and the functional
anatomy of the dopaminergic system has been intensively stud-
ied for many years. This is due in part to the known involvement
of this neurotransmitter in a range of cognitive, affective and
motor functions in healthy brain as well as a wide range of
diseases including Parkinson’s disease, schizophrenia, drug addic-
tion, ADHD, and pain disorders to name a few. Unsurprisingly,
there is a rapid proliferation of non-invasive brain imaging stud-
ies of both healthy and disease-related brain processes that are
associated with alterations in DA function, for instance, fMRI
studies of Parkinson’s disease (Hacker et al., 2012), risk-taking
behavior (Kohno et al., 2013), schizophrenia (Yoon et al., 2013),
reward prediction error (Chowdhury et al., 2013). This litera-
ture, which addresses pharmacological, disease- or task-related,
or genetic alterations in DA function, rests on the assumption
that differences in fMRI signals between conditions or subjects
are attributable to effects of the altered DA function on neuronal
activity. We suggest that sufficient data to support this assump-
tion does not yet exist. Although arguments have been made that
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fMRI signals may provide an adequate biomarker of DA release
(Knutson and Gibbs, 2007), this does not address the issue of how
to interpret stimulus/task evoked changes in neuronal activity in
the context of altered DA function. In addition, we know that the
long established vasoactive properties of dopamine are capable of
producing complex effects upon the relationship between DA sig-
naling, neurovascular coupling and fMRI responses in subcortical
structures (Devonshire et al., 2004; Choi et al., 2006; Shih et al.,
2009; Jenkins, 2012; Mandeville et al., 2013).
Due in part to its non-quantitative nature, alterations in base-
line parameters including metabolism, cerebral blood flow, and
oxygenation renders fMRI signal interpretation vulnerable to the
effects of such changes upon both evoked responses and resting-
state measurements. As it has been shown that the magnitude of
stimulus-evoked BOLD responses is dependent upon such base-
line parameters (Shulman et al., 2007; Lu et al., 2008), the effects
of changes in dopaminergic neurotransmission upon local base-
line conditions such as cerebral blood flow and brain metabolism
is an important potential confound. In relation to this, direct reg-
ulation of brain microvasculature tone by dopamine has been
demonstrated (Krimer et al., 1998; Choi et al., 2006; Kowianski
et al., 2013) and such vasomotor regulation has the capacity to
modulate measured fMRI signal changes (Tian et al., 2010), with
these effects occurring independently of neurogenic neurovascu-
lar coupling and this potentially confounding interpretation of
fMRI data. For instance, Arthurs et al. (2004)measured the effects
of the selective dopamine D2 receptor antagonist sulpiride on
electrophysiological and fMRI responses in human subjects and
using path analysis estimated that 84% of the drug effect on fMRI
responses to stimulation occurred via direct effects upon hemo-
dynamics, rather than neuronal responses themselves (Arthurs
et al., 2004).
fMRI is also widely used to investigate the role of 5-HT in nor-
mal function, disease processes, and therapeutic drug effects in
a wide range of human and animal models (Hariri et al., 2002;
Hariri and Weinberger, 2003; Del-Ben et al., 2005, 2008; Mckie
et al., 2005; Stark et al., 2006, 2008; Rao et al., 2007; Tanaka
et al., 2007; Graeff and Del-Ben, 2008; Munafo et al., 2008).
Within human fMRI studies, responses in structures receiv-
ing serotonergic input appear to be profoundly influenced by
synaptic 5-HT, with up to 42% of fMRI response variability
attributable to availability of the 5-HT transporter (Rhodes et al.,
2007). Windischberger et al. (2010) report a powerful modula-
tion of BOLD responses to stimuli by selective serotonin reuptake
inhibitors (SSRIs) that was specific to regions receiving dense
serotonergic projections. However, many research studies point
to a complex role for serotonin in neurovascular coupling (Cauli
et al., 2004; Hamel, 2006), vascular reactivity (Bonvento et al.,
1997) and for the interpretation of BOLD fMRI signals in terms
of spiking or synaptic activity (Rauch et al., 2008). Additionally,
the well-established influence of ascending serotonergic projec-
tions on the cerebral vasculature and microvascular tone (Toda
and Fujita, 1973; Dieguez et al., 1981; Cohen et al., 1996, 1999)
provide strong potential for modulation of vascular compliance
and therefore BOLD signal dynamics (Behzadi and Liu, 2005;
Boas et al., 2008). This severely complicates (a) the interpretation
of neuroimaging signals from structures receiving serotonergic
input, and (b) comparisons of task-evoked responses between
conditions involving altered 5-HT function.
LIMITATIONS OF ANIMAL MODELS FOR NEUROVASCULAR
RESEARCH
Although work in animal models is essential to advance the
capabilities of hemodynamic neuroimaging methods to estimate
neuronal activity in humans, there are a number of important
limitations associated with their use. A major concern is the use
of anesthesia in the vast majority of animal research carried out
in this field. Anesthesia is used for two main purposes. Firstly,
as many of the techniques used to study neuronal, neurovascular
and hemodynamic processes are invasive, anesthesia is necessary
in order to prevent suffering associated with (for instance) the
placement of recording electrodes. Secondly, anesthesia is often
used in order to prevent movement of the animal during data col-
lection. It is possible to conduct both imaging (e.g. using fMRI or
optical techniques) and electrophysiological experiments in un-
anaesthetized animals and indeed this approach has been taken
by a number of laboratories (see below). For small animal imag-
ing in particular therefore, anesthesia is frequently used chiefly to
prevent movement, avoiding the need for restraint and/or length
animal training protocols. Because all general anesthetics have
at least moderate effects upon normal physiological regulation
(for example blood pressure, blood oxygenation, thermoregu-
lation) it is usually necessary to perform additional invasive
procedures (even if the imaging technique is itself non-invasive)
in order to enable normal physiology to restored, monitored and
maintained.
Using anesthesia in animal research models has important
consequences for translation of findings from in vivo experimen-
tal research to the human neuroimaging arena (where subjects are
rarely imaged under anesthesia). Previous research in our labora-
tory and elsewhere has indicated that anesthetic agents disrupt
neurovascular coupling in a number of ways (Lahti et al., 1999;
Nakao et al., 2001; Brevard et al., 2003; Sicard et al., 2003; Martin
et al., 2006b, 2012; Luo et al., 2007; Tsurugizawa et al., 2010;
Fukuda et al., 2013), including via alterations in baseline hemo-
dynamic parameters (Shulman et al., 1999; Hyder et al., 2002).
A recent study comparing the effects of four different anesthetics
on BOLD fMRI responses in mice found that response differences
could largely be explained by differing systemic effects of the stim-
uli attributable to the different anesthetic conditions (Schroeter
et al., 2014).
A relatively consistent finding is that anesthetics significantly
delay the hemodynamic response function (Martin et al., 2006b;
Huttunen et al., 2008; Franceschini et al., 2010) and although
a recent study comparing fMRI BOLD responses in awake and
anesthetized marmosets found the opposite effect (more pro-
tracted responses in awake animals, Liu et al., 2013), the authors
suggest this was in turn the result of the much larger responses
observed and consequent increases in venous drainage time.
A further complication is that different anesthetic agents disrupt
neurovascular coupling in different ways. This may be particu-
larly problematic for pharmacological neuroimaging studies. For
example Du et al. (2009) demonstrated anesthetic-dependent
effects upon hemodynamic changes induced by cocaine including
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alterations in the coupling between different hemodynamic mea-
sures. A study investigating the role of nitric oxide in neurovas-
cular coupling found differences between awake and anesthetized
conditions that were in turn attributable to the deleterious effects
of the anesthetic agent upon the magnitude of stimulus-evoked
cerebral blood flow changes (Nakao et al., 2001). For a more in
depth discussion of the effects of anesthesia in studies of neu-
rovascular coupling the reader is directed to a recent review paper
(Masamoto and Kanno, 2012).
Much human fMRI engages subjects in complex cognitive
tasks which involve activity within, and communication between,
networked structures. Models of many relevant cognitive and
affective processes such as learning, memory and attention have
been established in awake behaving animals, as well as capabil-
ities to study disease-relevant alterations in these functions. An
additional problem with the use of anesthesia in animal mod-
els therefore is that it limits the possibilities for investigating
neurovascular function, and therefore improving our under-
standing neuroimaging signals, in the context of these “higher-
order” brain functions. Although a number of laboratories have
developed procedures for conducting fMRI or other hemody-
namic measurement procedures in awake animals (Martin et al.,
2002, 2013; Brevard et al., 2003; Sicard et al., 2003; Chin et al.,
2011; Desai et al., 2011; Brydges et al., 2013; Liu et al., 2013;
Pisauro et al., 2013; Takuwa et al., 2013), and a few stud-
ies also report on the neuronal signals underlying the hemo-
dynamic and/or fMRI responses (Lipton et al., 2006; Martin
et al., 2006b; Goense and Logothetis, 2008; Sirotin and Das,
2009; Desai et al., 2011; Liu et al., 2013), this work continues
to focus almost exclusively on cortical structures. In addition,
the effects of stress, especially where animals are restrained,
must be carefully taken into account as this is likely to have
a range of general physiological and neurophysiological effects.
This is particularly the case were animal models of neuropsy-
chiatric illness or related drug treatments are being studied. It
will also be a challenge to establish animal models for cogni-
tive or behavioral neuroscience in the context of the appara-
tus generally required for investigation of neuroimaging signals
and neurovascular coupling (as outlined in section Investigating
neuroimaging signals using experimental animal models and
Table 1), where restraint is required. To reduce restraint stress
and allow more sophisticated experimental designs, methods
for fixing experimental animals with respect to data acquisition
apparatus but permitting engagement in cognitive tasks have
recently been reported (e.g. Dombeck et al., 2007), and one
study reports a method whereby rats voluntarily engage with
head-restraint apparatus to allow functional brain imaging (using
2PLSM).
FUTURE RESEARCH CHALLENGES AND POSSIBILITIES
We suggest that a key contribution of future research stud-
ies in animal models will be the investigation of neuronal-
hemodynamic-neuroimaging signal relationships in subcortical
structures, using both awake and anesthetized animals. To opti-
mize the translation of neurovascular coupling data from animal
studies to improving neural signal estimation in human fMRI,
it will also be important to study neurovascular coupling in the
context of information processing or in behavioral paradigms
that more closely reflect research designs used in human sub-
jects. A major challenge in this respect will be the use of restraint
in most of the current awake animal studies. A small number
of laboratories have already successfully investigated affective or
cognitive processes using fMRI in awake rats (e.g. see review
by Ferris, 2014; also Brydges et al., 2013; Zhao et al., 2014a)
and the combination of these approaches with either concur-
rent measurement of neuronal data, or careful synthesis of new
hemodynamic data with existing data regarding underlying neu-
ronal activity, will provide important insights. Methods have also
been recently developed for use in rodents that utilize virtual
reality technology in order to provide head-fixed animals with a
pseudo-environment with which they can interact (Harvey et al.,
2009; Scott et al., 2013). Adaptations of these techniques may
further provide key insights into the neuronal events that fMRI
signals report on whilst the brain is engaged in relatively complex
tasks.
Technological developments are increasing the possibilities
to investigate the neuronal basis of hemodynamic neuroimag-
ing signals directly in humans. For example, combining EEG
with fMRI (EEG-fMRI) is an approach that has primarily been
deployed to marry the relatively high spatial resolution of fMRI
with the high temporal resolution of EEG for cognitive neu-
roscience research purposes (Huster et al., 2012; Laufs, 2012).
This approach may also provide insights into neurovascular cou-
pling in human subjects (Wan et al., 2006; Diukova et al., 2012;
Huster et al., 2012; Mayhew et al., 2013; Mullinger et al., 2013)
although the spatial and temporal mismatch of the measure-
ments made by each technique will pose a number of chal-
lenges: the spatial and temporal domains from which data are
sampled are very different. Other approaches include simultane-
ous near infra-red spectroscopy (NIRS) and EEG (Moosmann
et al., 2003), combined MEG and NIRS (e.g. Mackert et al.,
2004) or diffuse optical imaging combined with MEG (Ou
et al., 2009). Most recently, Fabiani et al. (2014) report on
a combined optical spectroscopy, event-related potential and
fMRI study of change in neurovascular function in normal
aging.
SUMMARY
As non-invasive brain imaging techniques are used to address
an increasingly diverse range of questions relevant to both brain
function and dysfunction, it will become more important that
our understanding of the neurophysiological basis of these signals
is specific to the brain structure, disease context, pharmaco-
logical, or task-related effects under investigation. Fortunately
a wide range of experimental tools, including combinations of
methods that optimize our ability to probe neuroimaging and
neuronal signal relationships, are now available in experimental
animals. It will be important that these approaches continue to
develop to enable neurovascular coupling to be probed in contexts
established in behavioral neuroscience. Simultaneously, technical
advances in human research studies that allow neurovascular cou-
pling to be probed directly will help detail a more comprehensive
empirical framework for estimating neural signals in the human
brain from hemodynamic proxies.
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